Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial.
This email address is used for sending the document.